SFRP1 and ovarian carcinoma: SFRP1 SFRP2 and SFRP5 are methylated in ovarian cancer [195], and experimental overexpression or knockdown, demonstrated that epigenetic silencing of SFRP5 was related to tumour growth, invasion (via EMT) and chemosensitivity in ovarian cancer [196].